NCT06264245 Users of Remote Conferencing and Compression of Sound Dynamics : Auditory Effects
| NCT ID | NCT06264245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut Pasteur |
| Condition | Auditory Perception |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-06-01 with a primary completion date of 2026-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The COMPRESSED project is a descriptive, bi-centric and non-invasive study carried out by the CERIAH - IDA - Institut Pasteur and the Haute École Léonard de Vinci in Brussels on volunteer participants identified in two groups : * be subject to high exposure to compressed sound, as defined by professional participation in events on broadcast platforms using sound signal processing systems, over the last 3 years, * be subject to moderate or limited exposure to compressed and manipulated sound, equivalent to that of a student following certain distance learning courses. on a videoconferencing platform, alternating with other face-to-face courses, with the ability to listen during breaks, which have been taught for a maximum of 2 years. The main objective of the COMPRESSED study is to evaluate the auditory effects of exposure to manipulated sounds (compression, filtering, equalisation, accentuation, etc.) from sound distribution platforms on the auditory system of participants who are regularly exposed to these sounds as a result of their professional activity.
Eligibility Criteria
Inclusion Criteria: For all participants: * Age 18 or over, * Work with platforms using sound signal processing systems, * Fluent in English, * Fluent in French, * Declare that they have no hearing loss. For participants in the high exposure group: \- Have had a professional activity over the last three years using broadcasting platforms with sound signal processing systems, For participants in the moderate or limited exposure group: \- Have worked between one semester and two years with platforms using sound signal processing systems. Exclusion Criteria: * Conductive or mixed hearing loss, i.e. where the hearing loss affects both the outer and/or middle ear and the inner ear. * Have an asymmetric hearing loss, i.e. a difference in average hearing loss between the left and right ear of more than 20 dB, * Have a history of otitis and/or an ENT disease that permanently affects hearing (vestibular schwannoma, Ménière's disease, sudden or fluctuating deafness, congenital hypoacusis), * Not fluent in English * Be under guardianship, * Deprived of liberty by judicial or administrative decision, or subject to legal protection.
Contact & Investigator
Paul Avan, MD
PRINCIPAL INVESTIGATOR
CERIAH
Frequently Asked Questions
Who can join the NCT06264245 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Auditory Perception. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06264245 currently recruiting?
Yes, NCT06264245 is actively recruiting participants. Contact the research team at celine.quinsac@pasteur.fr for enrollment information.
Where is the NCT06264245 trial being conducted?
This trial is being conducted at Brussels, Belgium, Paris, France.
Who is sponsoring the NCT06264245 clinical trial?
NCT06264245 is sponsored by Institut Pasteur. The principal investigator is Paul Avan, MD at CERIAH. The trial plans to enroll 200 participants.